Population
37 children and adolescents with synovial sarcoma treated at St Jude Children's Research Hospital over a…
Design
Cohort
Follow-up
5-year survival estimated
Authors
Loading...
Tumor group stratification may guide monitoring intensity in pediatric synovial sarcoma; leaves open whether adjuvant chemotherapy benefits resected high-risk cases.
In children and adolescents with synovial sarcoma, tumor invasiveness and grade independently predict overall and progression-free survival, suggesting a need for adjuvant chemotherapy in resected cases with unfavorable features.
Pappo et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: